本文从中国医药制造业的发展现状出发,对中国医药制造业的竞争实力、竞争潜力、竞争环境以及竞争态势进行了综和评价分析;得出经济规模不大已经成为制药我国医药制造业 R&D投入和技术创新能力提升与发展的重要因素的结论,并且提出了提高我国医药制造业国际竞争力需要重点解决的6个关键性的问题。

Starting with the status quo of the pharmaceutical industry in China this article makes a comprehensive assessment and analysis of the competitive strength, potential, environment and stance of China's pharmaceutical industry, drawing the conclusion that the country' s moderate scale of pharmaceutical industry has become a vital factor which restrains its investment in R&D and its enhancement and development of the capabilities of technical innovation in pharmaceutical industry, and puts forward six key problems which should necessarily be solved in the improvement of international competitiveness of China' s pharmaceutical industry.

中国科学院“科学与社会系列报告”项目:《2005年高技术发展报告》，负责人：穆荣平；国家自然科学基金委项目(79970051)：高技术产业国际竞争力评价方法研究，负责人：穆荣平。